Search / Trial NCT00002295

A Study of Isoprinosine in Patients With Severe AIDS

Launched by NEWPORT PHARMACEUTICALS INTERNATIONAL · Aug 30, 2001

Trial Information

Current as of November 03, 2024

Completed

Keywords

Infusions, Intravenous Drug Evaluation Administration, Oral Acquired Immunodeficiency Syndrome Aids Related Complex Zidovudine Biological Availability

Description

No description provided

Gender

ALL

Eligibility criteria

  • Exclusion Criteria
  • Co-existing Condition:
  • Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer are excluded.
  • Concurrent Medication:
  • Excluded:
  • * Steroids.
  • * Cytotoxic immunosuppressive agents.
  • * Radiotherapy.
  • The following are excluded:
  • * Critically ill patients.
  • * Patients receiving steroids, cytotoxic immunosuppressive agents, radiotherapy.
  • * Patients who have received any other immunotherapy.
  • * Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer.
  • Prior Medication:
  • Excluded:
  • * Any other immunotherapy.
  • Patients with severe AIDS and specified laboratory immunologic defects.

About Newport Pharmaceuticals International

Newport Pharmaceuticals International is a leading biopharmaceutical company dedicated to advancing innovative therapies that address unmet medical needs across various therapeutic areas. With a strong focus on research and development, Newport Pharmaceuticals harnesses cutting-edge science and technology to create effective treatments aimed at improving patient outcomes. The company is committed to conducting rigorous clinical trials that adhere to the highest ethical standards, ensuring safety and efficacy while fostering collaboration with healthcare professionals and regulatory bodies. Through its dedication to innovation and excellence, Newport Pharmaceuticals International strives to make a meaningful impact on global health.

Locations

Laguna Hills, California, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials